Pyoderma gangrenosum triggered by secukinumab in a patient with palmoplantar pustulosis. [PDF]
An Bras DermatolWang H, Sun J.
europepmc +1 more source
Correlation of lymphocyte-to-monocyte, platelet-to-lymphocyte, and neutrophil-to-lymphocyte ratios with skin-symptom improvement following antimicrobial treatment in palmoplantar pustulosis. [PDF]
J Pharm Health Care SciIwayama K +6 more
europepmc +1 more source
Efficacy of IL-23 inhibitors in axial involvements of chronic non-bacterial osteitis with palmoplantar pustulosis: a case series. [PDF]
Rheumatology (Oxford)Yamamoto H +4 more
europepmc +1 more source
Is palmoplantar pustulosis combined with hip involvement a SAPHO syndrome? [PDF]
Postepy Dermatol AlergolSun Q, Meng F, Chen N, Li C, Ying Z.
europepmc +1 more source
Corrigendum to Practice Patterns of Palmoplantar Pustulosis: Patient Demographics and Treatment Options. [PDF]
J Psoriasis Psoriatic Arthritis, 2023 europepmc +1 more source
Successful treatment of refractory palmoplantar pustulosis using JAK-1 inhibitors and TYK-2 inhibitors: a real-world retrospective study. [PDF]
Postepy Dermatol AlergolKailani Z, Aldahash R, Abu-Hilal M.
europepmc +1 more source
Determination of Risk Factors Influencing Psoriatic Arthritis Screening and Evaluation Questionnaire Scores in Palmoplantar Pustulosis: Post Hoc Analysis of EPPPIK Study. [PDF]
Dermatol Ther (Heidelb)Kim BS +13 more
europepmc +1 more source